Further evidence on mitochondrial targeting of β-amyloid and specificity of β-amyloid-induced mitotoxicity in neurons

Neurodegenerative Diseases

Volumn 8, Issue 5, 2011, Pages 331-344

  Tillement, Laurent ^a,b   Lecanu, Laurent ^a,b,c   Papadopoulos, Vassilios ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Amyloid peptide; Adenylate kinase; Alzheimer's disease; Mitochondria; Neuroprotection; Neurosteroids

Indexed keywords

ADENYLATE KINASE; AMYLOID BETA PROTEIN[1-42]; CAMPTOTHECIN; CAPROSPINOL; CYTOCHROME C OXIDASE; DNA; NEUROPROTECTIVE AGENT; STEROID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MEMBRANE PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TARGETING SIGNAL; MITOSIS; NERVE CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TERTIARY STRUCTURE; RAT; RESPIRATORY CHAIN;

AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; CYTOTOXINS; DRUG DELIVERY SYSTEMS; EXTRACELLULAR SPACE; HEK293 CELLS; HEP G2 CELLS; HUMANS; MITOCHONDRIA; NEURONS; PEPTIDE FRAGMENTS;

EID: 79958790879     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000323264     Document Type: Article

References (32)

1. Shastry BS, Giblin FJ: Genes and susceptible loci of Alzheimer's disease. Brain Res Bull 1999;48:121-127. (Pubitemid 29177387)
2. Tillement JP, Lecanu L, Papadopoulos V: Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological options. Pharmacology 2010;85:1-17.
3. Tillement L, Lecanu L, Yao W, Greeson J, Papadopoulos V: The spirostenol (22R, 25R)-20α-spirost-5-en-3β-yl hexanoate blocks mitochondrial uptake of Aβ in neuronal cells and prevents Aβ-induced impairment of mitochondrial function. Steroids 2006;71:725-735. (Pubitemid 43994018)
4. Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad B, Glaser E, Ankarcrona M: The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 2008;105:13145-13150.
5. Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, Schachner M: Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol Psychiatry 2008;13:953-969.
6. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE: Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 2009;30:1574-1586.
7. Rhein V, Baysang G, Rao S, Meier F, Bonert A, Muller-Spahn F, Eckert A: Amyloid-β leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 2009;29:1063-1071.
8. Lecanu L, Rammouz G, McCourty A, Sidahmed EK, Greeson J, Papadopoulos V: Caprospinol reduces amyloid deposits and improves cognitive function in a rat model of Alzheimer's disease. Neuroscience 2010;165:427-435.
9. Burman JL, Hamlin JN, McPherson PS: Scyl1 regulates Golgi morphology. PLoS One 2010;5:e9537.
10. Komeili A, Vali H, Beveridge TJ, Newman DK: Magnetosome vesicles are present before magnetite formation, and MamA is required for their activation. Proc Natl Acad Sci USA 2004;101:3839-3844. (Pubitemid 38386632)
11. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
12. Bloom GS, Brashear TA: A novel 58-kDa protein associates with the Golgi apparatus and microtubules. J Biol Chem 1989;264:16083-16092. (Pubitemid 19238369)
13. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR: Intraneuronal Aβ42 accumulation in human brain. Am J Pathol 2000;156:15-20. (Pubitemid 30644433)
14. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H: ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 2004;304:448-452. (Pubitemid 38495942)
15. Singh P, Suman S, Chandna S, Das TK: Possible role of amyloid-β, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease. Bioinformation 2009;3:440-445.
16. Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N: Importing mitochondrial proteins: machineries and mechanisms. Cell 2009;138:628-644.
17. Klein WL: Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 2002;41:345-352.
18. Lecanu L, Tillement L, Rammouz G, Tillement JP, Greeson J, Papadopoulos V: Caprospinol: moving from a neuroactive steroid to a neurotropic drug. Expert Opin Investig Drugs 2009;18:265-276.
19. Cranwell-Bruce LA: Drugs for Alzheimer's disease. Medsurg Nurs 2010;19:51-53.
20. Lemere CA, Masliah E: Can Alzheimer disease be prevented by amyloid-β immunotherapy? Nat Rev Neurol 2010;6:108-119.
21. Yao ZX, Han Z, Xu J, Greeson J, Lecanu L, Papadopoulos V: 22R-Hydroxycholesterol induces differentiation of human NT2 precursor (Ntera2/D1 teratocarcinoma) cells. Neuroscience 2007;148:441-453. (Pubitemid 47362504)
22. Lecanu L, Yao W, Teper GL, Yao ZX, Greeson J, Papadopoulos V: Identification of naturally occurring spirostenols preventing β-amyloid-induced neurotoxicity. Steroids 2004;69:1-16. (Pubitemid 38050297)
23. Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B, Ankarcrona M: Mitochondrial γ-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J 2010.
24. Ferreiro E, Oliveira CR, Pereira CM: The release of calcium from the endoplasmic reticulum induced by amyloid-β and prion peptides activates the mitochondrial apoptotic pathway. Neurobiol Dis 2008;30:331-342.
25. Galindo MF, Jordan J, Gonzalez-Garcia C, Cena V: Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria. Br J Pharmacol 2003;139:797-804. (Pubitemid 36819607)
26. Munoz-Pinedo C, Guio-Carrion A, Goldstein JC, Fitzgerald P, Newmeyer DD, Green DR: Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc Natl Acad Sci USA 2006;103:11573-11578. (Pubitemid 44182493)
27. 2+ in the absence of respiratory substrate. J Bioenerg Biomembr 2008;40:619-623.
28. Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Gotz J: Aβ and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 2010;10:1621-1633.
29. Crews L, Tsigelny I, Hashimoto M, Masliah E: Role of synucleins in Alzheimer's disease. Neurotox Res 2009;16:306-317.
30. Yang K, Lei G, Jackson MF, Macdonald JF: The involvement of PACAP/VIP system in the synaptic transmission in the hippocampus. J Mol Neurosci 2010.
31. Yasuhara O, Akiguchi I, Nakamura S, Kinoshita A, Ikemoto A, Kawamoto Y, Kimura J, Funakoshi A, Tateishi K, McGeer PL: Pancreastatin-like immunoreactivity in globular dystrophic neurites of senile plaques in brains of patients with Alzheimer's disease. Neurosci Lett 1996;208:167-170.
32. Lachmann HJ, Gillmore JD: Renal amyloidosis. Br J Hosp Med (Lond) 2010;71:83-86.